PATRICIA NEUMAN: Open Payments
NPI 1275920597 · RICHLAND, WA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$405 in 18 payments from 10 companies in 2025. Trend: 2023 $1,005 · 2024 $717 · 2025 $405
Food & beverage: $405
| Company | Payments | Amount |
|---|---|---|
| Corcept Therapeutics | 6 | $174 |
| Xeris Pharmaceuticals, Inc. | 3 | $68 |
| ABBVIE INC. | 2 | $39 |
| Abbott Laboratories | 1 | $20 |
| AstraZeneca Pharmaceuticals LP | 1 | $19 |
| Novartis Pharmaceuticals Corporation | 1 | $19 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $18 |
| Amgen Inc. | 1 | $18 |
| Lilly USA, LLC | 1 | $15 |
| Novo Nordisk Inc | 1 | $14 |
Products named: Korlym, GVOKE HYPOPEN, FREESTYLE LIBRE 3, UBRELVY, SAPHNELO, LEQVIO, QULIPTA, REPATHA.
Industry payments across WA — which companies pay providers there.
